Marchele Johnson
Family · Kaufman, TXNPI 1831537497
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Biohaven Pharmaceutical Holding Company Ltd. at 51.1% of the total. Reporting peaked in 2022 at $2,227 and has fallen 76.9% since, to $514 in 2023.
Across 105 payments — averaging $26.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$1K
- Collegium Pharmaceutical, Inc.$296
- AbbVie$233
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$172
- Scilex Pharmaceuticals Inc.$117
- Teva Pharmaceuticals USA, Inc.$112
- plus $437 from 12 others
What the payments were for
- Consulting fees$80029%
- Travel & lodging$41715%
- Food & beverage$1,56056%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $1,430 |
| Collegium Pharmaceutical, Inc. | 21 | $296 |
| AbbVie | 24 | $233 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $172 |
| Scilex Pharmaceuticals Inc. | 6 | $117 |
| Teva Pharmaceuticals USA, Inc. | 5 | $112 |
| GRT US Holding, Inc. | 10 | $110 |
| Pfizer | 3 | $53 |
| Valinor Pharma, LLC | 2 | $44 |
| Almatica Pharma LLC | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Nevro Corp. | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Amgen | 1 | $21 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,104
How this compares
$2,797 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Kaufman
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.